Open Menu

call-now-button

CORE

Rate this Condo
(23 votes)

core-modern-homesCORE Modern Homes is a new unique townhouse development by Mazenga Building Group. The project is priced from $1,300,000 and features 7 unique town homes with sizes 2000 square feet or more. Core is estimated to be completed in late 2015 and will be located on located at 538 Eglinton Avenue East at Davisville in Toronto.

 

 

 

Photo Gallery

Condo Facts

  • Price Range: $1,345,000 - $1,589,000
  • Square Footage: 1974 Sqft - 2478 Sqft
  • Move In: 2015
  • Maintenance Fees: $169 / month
  • Floors: 3
  • Units: 7
  • Neighbourhood: Leaside
  • Parking Cost: GARAGE
  • Lifestyle: Lofthouse, 3-Storey

Details

Model Bed Bath Sqft Price
HOME 1 3+ 2.5 2515 -
HOME 2 3+ 2.5 2478 -
HOME 3 3+ 2.5 2645 -
HOME 4 3+ 2.5 2067 -
HOME 5 3+ 2.5 2037 -
HOME 6 3+ 2.5 1974 -
HOME 7 3+ 2.5 2272 -

Need Help?

Condo Royalty is standing by, ready to help you.

Contact us !

Search Toronto Townhomes & Lofts on Yonge, Bay, Bloor, King, Adelaide & Lakeshore.

 


Condo Royalty is a 100% transparent Condo platform for all new Condo & Townhouse projects for sale in the GTA

Search, Download and Share Condo Price lists, Floor plans, Videos, Pictures, Facts and Compare new Condo developments all in one website.

condo-royalty-logo
 
ByCondo Royalty -
 

Disclosure: CondoRoyalty, this website, and commentary herein are provided solely for the purpose to openly provide information to the public. The content of this website is for informational and conceptual purposes only. Prices, specifications, and architectural renderings are subject to change without notice. E. &O.E. Illustrations are artist's concept. CondoRoyalty is an open platform to share information to the public and does not provide any real estate, brokerage, appraisal, mortgage, legal or any other real property related services. Please consult a qualified professional before making any financial decisions. If you are dissatisfied with this website or with this agreement, your sole and exclusive remedy is to discontinue using this website. Please refer to our Privacy Policy and Legal Disclaimer for reference.